Fresenius Medical Care AG & Co. KGaA (ETR:FME) Given a €37.00 Price Target by Deutsche Bank Aktiengesellschaft Analysts

Deutsche Bank Aktiengesellschaft set a €37.00 ($38.14) price objective on Fresenius Medical Care AG & Co. KGaA (ETR:FMEGet Rating) in a report released on Tuesday, Borsen Zeitung reports.

Other equities research analysts have also issued research reports about the stock. UBS Group set a €38.00 ($39.18) target price on shares of Fresenius Medical Care AG & Co. KGaA in a report on Friday, July 29th. JPMorgan Chase & Co. set a €23.00 ($23.71) price objective on shares of Fresenius Medical Care AG & Co. KGaA in a report on Friday, July 29th. Warburg Research set a €62.00 ($63.92) price target on shares of Fresenius Medical Care AG & Co. KGaA in a report on Tuesday, May 10th. Credit Suisse Group set a €61.00 ($62.89) target price on shares of Fresenius Medical Care AG & Co. KGaA in a research report on Thursday, May 5th. Finally, Berenberg Bank set a €76.70 ($79.07) target price on shares of Fresenius Medical Care AG & Co. KGaA in a research report on Wednesday, July 27th.

Fresenius Medical Care AG & Co. KGaA Stock Performance

Shares of FME opened at €36.91 ($38.05) on Tuesday. The company has a current ratio of 1.26, a quick ratio of 0.79 and a debt-to-equity ratio of 91.78. The stock has a market capitalization of $10.82 billion and a P/E ratio of 12.09. The firm’s fifty day simple moving average is €47.24 and its two-hundred day simple moving average is €55.00. Fresenius Medical Care AG & Co. KGaA has a 12 month low of €37.37 ($38.53) and a 12 month high of €69.96 ($72.12).

About Fresenius Medical Care AG & Co. KGaA

(Get Rating)

Fresenius Medical Care AG & Co KGaA provides dialysis care and related dialysis care services in Germany, North America, and internationally. It offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure.

Recommended Stories

Receive News & Ratings for Fresenius Medical Care AG & Co. KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fresenius Medical Care AG & Co. KGaA and related companies with MarketBeat.com's FREE daily email newsletter.